Login
← Go Back
Concord Drugs
CONCORD · Pharma > Pharmaceuticals & Drugs Listing date: Feb. 23, 2015
Stock Price vs Company Growth
1d
2.4%
1w
1.1%
1m
4.4%
3m
5.9%
6m
15.0%
1y
38.1%
5y
19.6%
10y
1.1%
all
12.5%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 76.6 2.4%
71.7
89
Company Overview
Sales
78.8 Cr
Growth: 10.8%
Profit after Tax
1.06 Cr
Growth: 86.4%
Micro Cap
101 Cr
P/E: 81.5x
Industry P/E: 33.7x
Fundamentals
Sales (Cr) ₹ 78.8
Growth 10.8%
EBITDA 5.8%
P/S 1.3x
Dividend 0.0%
P/E 81.5x
Book Value ₹ 36.8
PEG Ratio 7.4x
ROE 2.7%
P/B 2.0x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
:Concord Drugs is engaged in developing new products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery.
Investors (6)
s.jhansi
s.manoj....
s.nagi.r...